Group Asks SEC To Review CVS Stock Sales

Law360, New York (April 22, 2010, 7:41 PM EDT) -- A U.S. shareholder activist group has urged federal securities regulators to look into a number of stock sales made at CVS Caremark Corp. last year, claiming that executives made improper trades before the company disclosed information about the poor performance of its pharmacy benefit management segment.

CtW Investment Group, which is a CVS shareholder, sent a letter to the U.S. Securities and Exchange Commission on Thursday that accused top CVS executives of collecting millions of dollars by selling off company shares between August and November, when...
To view the full article, register now.